Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0001193125-25-307229

See Remarks sold 5,000 shares at $79.53 ($397,632)

  • See Remarks acquired 5,000 shares (option exercise)
  • See Remarks acquired 356 shares (grant or award)
  • See Remarks gave up 110 shares (to pay taxes)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Lyon Joseph Douglas See Remarks 2025-12-01 Option exercise 10b5-1 +5,000 $13.56 $67,800 15,277 D: show line 1 in the form
Lyon Joseph Douglas See Remarks 2025-12-01 Sale 10b5-1 −5,000 $79.53 $397,632 10,277 D: show line 2 in the form
Lyon Joseph Douglas See Remarks 2025-12-01 Grant or award 10b5-1 +178 $79.78 $14,201 10,455 D: show line 3 in the form
Lyon Joseph Douglas See Remarks 2025-12-01 Grant or award 10b5-1 +178 10,633 D: show line 4 in the form
Lyon Joseph Douglas See Remarks 2025-12-02 Shares withheld for taxes 10b5-1 −110 $79.78 $8,776 10,523 D: show line 5 in the form
Open-market sales · 5,000 sh · avg $79.53 · $397,632

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Lyon Joseph Douglas See Remarks 2025-12-01 Option exercise · Stock option (right to buy) 10b5-1 −5,000 11,571 D: show line 6 in the form
Loading xslF345X05/ownership.xml…